Skip to content
conflictLOW2026-04-23 12:26 UTC

Trump signs order to accelerate Ibogaine research for veterans with PTSD 

The order focuses on advancing studies of ibogaine, a Schedule I psychedelic drug, for use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideatiation, and opiod addiction.

ORIGINAL SOURCE →via Jerusalem Post
ADVERTISEMENT
⚡ STAY AHEAD

Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.

GET THE SUNDAY BRIEFING →

RELATED · conflict